U.S. Markets open in 1 hr

AbbVie Earnings, Revenue Beat in Q3

AbbVie Earnings, Revenue Beat in Q3

Investing.com - AbbVie (NYSE:ABBV) reported third quarter earnings that beat analysts' expectations on Friday and revenue that topped forecasts.

The firm reported earnings per share of $2.33 on revenue of $8.48B. Analysts polled by Investing.com anticipated EPS of $2.3 on revenue of $8.38B. That compared to EPS of $2.14 on revenue of $8.24B in the same period a year earlier. The company had reported EPS of $2.26 on revenue of $8.26B in the previous quarter.

AbbVie shares lost 0.69% to trade at $79.00 in pre-market trade following the report.


AbbVie follows other major Healthcare sector earnings this month

On October 15, J&J reported third quarter EPS of $2.12 on revenue of $20.73B, compared to forecasts of EPS of $2.01 on revenue of $20.08B.

Merck&Co earnings beat analysts' expectations on Tuesday, with third quarter EPS of $1.51 on revenue of $12.4B. Investing.com analysts expected EPS of $1.24 on revenue of $11.65B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Related Articles

AbbVie lifts 2019 profit forecast as Humira helps beat revenue estimates

Analysts slam Shell over buyback delay warning

Nasdaq to restart equity trading in Nordics and Baltics at 1200 GMT